193 related articles for article (PubMed ID: 11177543)
1. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.
Chen J; Reeves L; Cornetta K
Hum Gene Ther; 2001 Jan; 12(1):61-70. PubMed ID: 11177543
[TBL] [Abstract][Full Text] [Related]
2. Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors.
Lamers CH; Willemsen RA; van Elzakker PM; Gratama JW; Debets R
J Immunother; 2009 Apr; 32(3):272-9. PubMed ID: 19242373
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons.
Kiem HP; Heyward S; Winkler A; Potter J; Allen JM; Miller AD; Andrews RG
Blood; 1997 Dec; 90(11):4638-45. PubMed ID: 9373277
[TBL] [Abstract][Full Text] [Related]
4. Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector.
van der Loo JC; Liu BL; Goldman AI; Buckley SM; Chrudimsky KS
Hum Gene Ther; 2002 Jul; 13(11):1317-30. PubMed ID: 12162814
[TBL] [Abstract][Full Text] [Related]
5. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.
Lam JS; Reeves ME; Cowherd R; Rosenberg SA; Hwu P
Hum Gene Ther; 1996 Aug; 7(12):1415-22. PubMed ID: 8844200
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors.
Wilson CA; Ng TH; Miller AE
Hum Gene Ther; 1997 May; 8(7):869-74. PubMed ID: 9143913
[TBL] [Abstract][Full Text] [Related]
7. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K
Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630
[TBL] [Abstract][Full Text] [Related]
8. Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.
Ghani K; Wang X; de Campos-Lima PO; Olszewska M; Kamen A; Rivière I; Caruso M
Hum Gene Ther; 2009 Sep; 20(9):966-74. PubMed ID: 19453219
[TBL] [Abstract][Full Text] [Related]
9. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
Jin SY; Jung YT
Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
[TBL] [Abstract][Full Text] [Related]
10. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.
Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
[TBL] [Abstract][Full Text] [Related]
12. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
Printz M; Reynolds J; Mento SJ; Jolly D; Kowal K; Sajjadi N
Gene Ther; 1995 Mar; 2(2):143-50. PubMed ID: 7719931
[TBL] [Abstract][Full Text] [Related]
13. Transduction of human hematopoietic progenitor cells with retroviral vectors based on the gibbon ape leukemia virus.
Eglitis MA; Schneiderman RD
Biochem Biophys Res Commun; 1997 Feb; 231(2):477-80. PubMed ID: 9070304
[TBL] [Abstract][Full Text] [Related]
14. Infection of human cells with murine amphotropic replication-competent retroviruses.
Cornetta K; Nguyen N; Morgan RA; Muenchau DD; Hartley JW; Blaese RM; Anderson WF
Hum Gene Ther; 1993 Oct; 4(5):579-88. PubMed ID: 8280796
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells.
Bunnell BA; Kluge KA; Lee-Lin SQ; Byrne ER; Orlic D; Metzger ME; Agricola BA; Wersto RP; Bodine DM; Morgan RA; Donahue RE
Gene Ther; 1999 Jan; 6(1):48-56. PubMed ID: 10341875
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
17. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34(+) cells increases gene transfer mediated by GALV pseudotyped vectors.
Relander T; Brun AC; Olsson K; Pedersen L; Richter J
Mol Ther; 2002 Sep; 6(3):400-6. PubMed ID: 12231177
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.
Martineau D; Klump WM; McCormack JE; DePolo NJ; Kamantigue E; Petrowski M; Hanlon J; Jolly DJ; Mento SJ; Sajjadi N
Hum Gene Ther; 1997 Jul; 8(10):1231-41. PubMed ID: 9215740
[TBL] [Abstract][Full Text] [Related]
20. Detection of replication competent retrovirus and lentivirus.
Sastry L; Cornetta K
Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
